EUVIMEDEUVIMED entdecken
Open Access

ROR2 promotes invasion and chemoresistance of triple-negative breast cancer cells by activating PI3K/AKT/mTOR signaling

Xia DA, Han Ge, Junfeng Shi, Chunhua Zhu, Guozhu Wang, Yuan Fang, Jin Xu

Oncology Research · 2024

DOI: 10.32604/or.2024.045433 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2024. Verfasst von Xia DA und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Receptor Tyrosine Kinase-like Orphan Receptors, TOR Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsReceptor Tyrosine Kinase-like Orphan ReceptorsTOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktDrug Resistance, NeoplasmSignal TransductionPhosphatidylinositol 3-KinasesCell MovementNeoplasm InvasivenessHumansFemaleCell Line, TumorGene Expression Regulation, NeoplasticDoxorubicin

Stichwörter der Autor:innen

ApoptosisMetastasisPI3K/AKT/mTOR signalingProliferationReceptor tyrosine kinase-like orphan receptor 2Triplet-negative breast cancer

Substanzen

Receptor Tyrosine Kinase-like Orphan ReceptorsTOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktROR2 protein, humanPhosphatidylinositol 3-KinasesMTOR protein, humanDoxorubicin

Autor:innen und Institutionen

  • Department of Breast and Thyroid, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Department of Pathology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

Zitieren

APA

DA, X., Ge, H., Shi, J., Zhu, C., Wang, G., Fang, Y., & Xu, J. (2024). ROR2 promotes invasion and chemoresistance of triple-negative breast cancer cells by activating PI3K/AKT/mTOR signaling. Oncology Research. https://doi.org/10.32604/or.2024.045433

Vancouver

DA X, Ge H, Shi J, Zhu C, Wang G, Fang Y, et al. ROR2 promotes invasion and chemoresistance of triple-negative breast cancer cells by activating PI3K/AKT/mTOR signaling. Oncology Research. 2024. doi:10.32604/or.2024.045433

BibTeX
@article{DA2024,
  author = {DA, Xia and Ge, Han and Shi, Junfeng and Zhu, Chunhua and Wang, Guozhu and Fang, Yuan and Xu, Jin},
  title = {ROR2 promotes invasion and chemoresistance of triple-negative breast cancer cells by activating PI3K/AKT/mTOR signaling},
  journal = {Oncology Research},
  year = {2024},
  doi = {10.32604/or.2024.045433}
}
Kostenlos starten →